PharmaShots Magazine-July-2026 Edition

Shots: This edition explores AI-Powered Pharmaceutical Logistics, highlighting how artificial intelligence, predictive analytics, robotics, IoT, and digital twins are transforming pharmaceutical supply chains into intelligent, resilient, and patient-centric networks that optimize forecasting, manufacturing, warehousing, and global distribution. Through expert perspectives, feature stories, and regulatory insights, we examine the opportunities and challenges of AI-enabled pharmaceutical logistics—from…

ByAditya SinghJuly 9, 2026

NEWS

Insilico Medicine Collaborates with Takeda to Advance AI Drug Discovery

Shots: Insilico Medicine has entered into a strategic collaboration agreement with Takeda to advance clinically differentiated drug candidates across Takeda's therapeutic areas, using Insilico’s Pharma.AI platform Insilico will lead AI-driven discovery, while Takeda will advance selected candidates through clinical development & hold exclusive worldwide rights to develop, manufacture, & commercialize resulting therapeutics As per the…

ByRidhi RastogiJuly 2, 2026

THOUGHTSPOT

From Experimentation to Execution: Why Most AI Pilots in Pharma Stall

AI has moved beyond proof-of-concept on the clinical side of pharma, driving rapid discovery of new molecules. But post-market commercialization teams tell a different story: their boards are asking them to use AI to solve the problems caused by multiple rounds of layoffs, mounting pressure to do more with less, and a human capital fabric…

ByParth KhannaJune 17, 2026

MAGAZINE

PharmaShots Magazine-April-2026 Edition

Shots: AI is redefining compliance from reactive to predictive, as this April edition highlights how AI-powered systems are transforming regulatory oversight into a continuous, real-time, and data-driven function, enabling early risk detection, automated audits, and smarter regulatory collaboration across the pharma value chain. Strategic dealmaking and AI partnerships shape industry momentum, with March witnessing high-value…

ByAditya SinghApril 9, 2026

VIEWPOINTS

When Algorithms Decide Visibility: Ben Beckley, CEO of RevHealth on the Future of Pharma

Shots: AI is redefining visibility in pharma as it becomes the primary gateway to information, requiring companies to shift from content publishing to engineering discoverability with machine-readable, well-cited, and rapidly updated data to be included in AI-generated summaries Integrated, structured evidence is now critical for success in AI-driven environments, demanding modular, metadata-rich, and consistent data…

BySaurabh ChaubeyApril 6, 2026

PUBLICATIONS

THE IMPACT OF ARTIFICIAL INTELLIGENCE ON PHARMACEUTICAL AND LIFESCIENCES INDUSTRY

Abstract Just like the Internet in 1990’s, Artificial intelligence is now changing all aspects of our life and work. It’s impact is beginning to show in the industry and it is changing the life-sciences practice by fundamentally altering the way how medicines are discovered, developed, manufactured, approved, supplied and brought to market. In research and discovery, generative models and structure prediction systems shorten the path from target to lead and raise the ceiling…

ByRahul MittalMarch 24, 2026

PharmaShots Magazine-July-2026 Edition

Insilico Medicine Collaborates with Takeda to Advance AI Drug Discovery

From Experimentation to Execution: Why Most AI Pilots in Pharma Stall

PharmaShots Magazine-April-2026 Edition

When Algorithms Decide Visibility: Ben Beckley, CEO of RevHealth on the Future of Pharma

THE IMPACT OF ARTIFICIAL INTELLIGENCE ON PHARMACEUTICAL AND LIFESCIENCES INDUSTRY

Contact US

FOLLOW US